- Global Pharma News & Resources

Prezista - API Insight, 2019-2021: Historical & Forecasted Sales -

The "Prezista - API Insight, 2019" drug pipelines has been added to's offering.

Prezista - API Insight, 2019 provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Prezista. The report also highlights the patent details of Prezista.

Scope of the Report

  • A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
  • Patent information around Prezista in United States (US) and Europe (EU) has been highlighted
  • API manufacturers for Prezista in United States, Europe, China and India
  • The report contains historical and forecasted sales for Prezista till 2021
  • Enlists the market competition and emerging therapies in the space where Prezista operates

Reasons to Buy

  • Evaluate the marketing status of Prezista to exploit opportunities for generic Prezista development opportunities
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Prezista
  • API intelligence over Prezista and gaining primary intelligence over Active Ingredient manufacturers by country
  • Make more informed business decisions from insightful and in-depth analysis of Prezista's performance

Topics Covered

1. Prezista Overview

2. Prezista Global Sales Assessment

  • Prezista Historical Global Sales
  • Prezista Forecasted Global Sales

3. Product Description

  • Mechanism of Action
  • Pharmacodynamic Properties
  • Pharmacokinetic Properties

4. Product Details by Country

5. Patent Information

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit

View source version on

Editor Details

Last Updated: 25-Jan-2019